Lupin plans to make significant investments in Japan

25 Feb 2016 Evaluate

Lupin is planning to make significant investments in Japan, the second biggest pharmaceutical market in the world. The company is setting up a new plant in Japan and investing Rs 100 crore in a manufacturing facility in India which will cater to the Japanese market.

Lupin, which entered Japan through acquisitions, reported 9% year-on-year growth in its business in the country in the third quarter of financial year 2016.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2086.55 -3.60 (-0.17%)
16-Dec-2025 10:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1273.45
Cipla 1501.55
Zydus Lifesciences 922.05
Lupin 2086.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×